Ledger.Open graph →
SEC Form D · filed January 3, 2018

Expansion Therapeutics, Inc

Offering
$55.3M
Sold
$25.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DEL MAR, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Kevin Forrest, Ph.D · Del Mar, CAExec · DirectorCampbell Murray, M.B.B.S., M.B.A · Cambridge, MADirectorYujiro Hata, M.B.A · Del Mar, CADirectorMatthew Disney, Ph.D · Del Mar, CADirectorBeth Seidenberg, M.D · Menlo Park, CADirectorScott Rocklage, Ph.D · San Francisco, CADirectorJason Hafler, Ph.D · Bridgewater, NJDirectorKevin Forrest, Ph.D · Del Mar, CAExec · DirectorCampbell Murray, M.B.B.S., M.B.A · Cambridge, MADirectorYujiro Hata, M.B.A · Del Mar, CADirectorMatthew Disney, Ph.D · Del Mar, CADirectorBeth Seidenberg, M.D · Menlo Park, CADirectorScott Rocklage, Ph.D · San Francisco, CADirectorJason Hafler, Ph.D · Bridgewater, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗